文献速递糖尿病

收缩孔综合征与1型糖尿病无心白蛋白尿患者心血管疾病及全因死亡风险

Shrunken Pore Syndrome and Risk of Cardiovascular Disease and All-Cause Mortality in Individuals With Type 1 Diabetes With and Without Albuminuria.
PubMed 文献 · Diabetes Care · 2026-01-01

研究基于FinnDiane队列3769例1型糖尿病患者,探讨收缩孔综合征(SPS,eGFRcys/eGFRcr比值<0.7)与心血管疾病及全因死亡的关系。结果发现,在无白蛋白尿者中,SPS与心衰、外周动脉疾病和全因死亡风险显著相关;而在有白蛋白尿者中,SPS仅与心衰相关。

要点

  • 无白蛋白尿的1型糖尿病患者中,SPS与心衰、外周动脉疾病和全因死亡风险升高相关。
  • 有白蛋白尿者中,SPS仅与心衰风险相关,且eGFRcys和eGFRcr均与所有结局独立相关。
  • 联合评估eGFRcys与eGFRcr及其差异有助于早期识别无白蛋白尿1型糖尿病高危患者。

核心结论

  • 在无白蛋白尿的1型糖尿病患者中,SPS与心衰、外周动脉疾病和全因死亡风险增加相关。
  • 在有白蛋白尿的1型糖尿病患者中,SPS仅与心衰风险相关。

研究设计与样本

  • 研究纳入芬兰糖尿病肾病研究(FinnDiane)中3769例有血清肌酐和血清胱抑素C数据的1型糖尿病患者,包括有和无白蛋白尿者。

主要发现

  • SPS(eGFRcys/eGFRcr比值切点0.7)与冠心病或卒中无显著关联。
  • 在无白蛋白尿者中,SPS与心衰(HR 3.07,95%CI 1.47-6.38)、外周动脉疾病(HR 3.64,95%CI 1.75-7.57)和全因死亡(HR 3.08,95%CI 1.86-5.11)相关。
  • 在无白蛋白尿者中,eGFRcys/eGFRcr比值作为连续变量以及eGFRcys单独均与心衰、外周动脉疾病和全因死亡显著相关。
  • 在有白蛋白尿者中,SPS仅与心衰相关(HR 1.54,95%CI 1.02-2.33),eGFRcys/eGFRcr比值作为连续变量与任何结局均无关。
  • 在有白蛋白尿者中,eGFRcys和eGFRcr均与所有研究结局独立相关。

临床怎么用

  • 对于无白蛋白尿的1型糖尿病患者,可考虑联合评估eGFRcys和eGFRcr及其比值以早期识别心衰、外周动脉疾病和全因死亡高危个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association between "shrunken pore syndrome" (SPS), defined as a large discrepancy between estimated glomerular filtration rates based on cystatin C (eGFRcys) and creatinine (eGFRcr), and coronary artery disease (CAD), stroke, peripheral artery disease (PAD), heart failure (HF), and all-cause mortality in individuals with T1D with and without albuminuria. RESEARCH DESIGN AND METHODS: The study comprised 3,769 individuals with and without albuminuria from the Finnish Diabetic Nephropathy Study (FinnDiane) who had both serum creatinine (Scr) and serum cystatin C (SCysC) data available. RESULTS: SPS (eGFRcys/eGFRcr ratio cutoff 0.7) was not associated with CAD or stroke. In those with SPS but without albuminuria, the hazard ratios (HRs) for HF, PAD, and all-cause mortality were 3.07 (95% CI 1.47-6.38), 3.64 (95% CI 1.75-7.57), and 3.08 (95% CI 1.86-5.11). The associations between the eGFRcys/eGFRcr ratio as a continuous variable, as well as eGFRcys alone and HF, PAD, and all-cause mortality were significant in those without albuminuria. In individuals with albuminuria, SPS was only associated with HF (HR 1.54; 95% CI 1.02-2.33), whereas the eGFRcys/eGFRcr ratio as a continuous variable was not associated with any of the outcomes. On the contrary, both eGFRcys and eGFRcr were independently associated with all studied outcomes in those with albuminuria. CONCLUSIONS: Findings highlight the clinical potential of identifying individuals at increased risk of HF, PAD, and all-cause mortality at an early stage among those with T1D without albuminuria by evaluating both eGFRcys and eGFRcr and their discrepancy.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Harjutsalo V, Thorn LM, Sandholm N, et al. Shrunken Pore Syndrome and Risk of Cardiovascular Disease and All-Cause Mortality in Individuals With Type 1 Diabetes With and Without Albuminuria. Diabetes Care. 2026. PMID: 41842751. doi:10.2337/dc25-2987

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。